Patent details
EP3927347 Title: DRUG COMBINATION FOR USE IN A METHOD OF TREATING LIVER CANCER
Basic Information
- Publication number:
- EP3927347
- PCT Application Number:
- SE2020050175
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP207593617
- PCT Publication Number:
- WO2020171757
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DRUG COMBINATION FOR USE IN A METHOD OF TREATING LIVER CANCER
- French Title of Invention:
- MÉTHODES DE TRAITEMENT DE CANCERS DU FOIE À L'AIDE DE NUCLÉOTIDE DE DIOXOLANE ADMINISTRÉ PAR VOIE ORALE EN COMBINAISON AVEC UN ANTICORPS MONOCLONAL ANTI-PD1 OU ANTI-PDL1
- German Title of Invention:
- VERFAHREN ZUR BEHANDLUNG VON LEBERKREBS UNTER VERWENDUNG EINES ORAL VERABREICHTEN DIOXOLAN-NUKLEOTIDS IN KOMBINATION MIT EINEM MONOKLONALEN ANTI-PD1- ODER ANTI-PDL1-ANTIKÖRPER
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 25/01/2024
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 06/02/2024
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 27/12/2023
- Unitary Effect Registration Date:
- 06/02/2024
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 17/02/2020
- Grant date:
- 27/12/2023
- EP Publication Date:
- 29/12/2021
- PCT Publication Date:
- 27/08/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 27/12/2023
- EP B1 Publication Date:
- 27/12/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/02/2040
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 20/12/2023
- Name:
- Medivir Aktiebolag
- Address:
- P.O. Box 1086, 141 22 Huddinge, Sweden (SE)
Inventor
- Name:
- ALBERTELLA, Mark
- Address:
- Sweden (SE)
Priority
- Priority Number:
- 1950202
- Priority Date:
- 18/02/2019
- Priority Country:
- Sweden (SE)
Classification
- IPC classification:
- A61K 31/675; A61K 31/513; A61K 39/395; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202352
- Publication date:
- 27/12/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202410
- Publication date:
- 06/03/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|